MENLO PARK, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing […]
NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) — Tyme Technologies, Inc. (NASDAQ: TYME), a clinical-stage oncology biotechnology company developing metabolically-based […]
New recommendations highlight positive changes for PACE participants MOORESTOWN, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. […]